These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24852924)

  • 41. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
    Sonder JM; Balk LJ; van der Linden FA; Bosma LV; Polman CH; Uitdehaag BM
    Mult Scler; 2015 Dec; 21(14):1865-71. PubMed ID: 25257617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of frequency of fatigue syndrome in patients with multiple sclerosis].
    Łabuz-Roszak B; Pierzhała K; Kumor K; Wyrozumska K; Baran A; Werner A; Bak E; Jaźwiecka M
    Wiad Lek; 2009; 62(2):99-103. PubMed ID: 20141057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
    Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2009 Mar; 15(3):385-92. PubMed ID: 19153176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uveitis as a prognostic factor in multiple sclerosis.
    Shugaiv E; Tüzün E; Kürtüncü M; Kıyat-Atamer A; Çoban A; Akman-Demir G; Tugal-Tutkun I; Eraksoy M
    Mult Scler; 2015 Jan; 21(1):105-7. PubMed ID: 24948689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
    Hoang H; Laursen B; Stenager EN; Stenager E
    Mult Scler; 2016 Mar; 22(3):347-53. PubMed ID: 26041803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life in Polish patients with multiple sclerosis.
    Mitosek-Szewczyk K; Kułakowska A; Bartosik-Psujek H; Hożejowski R; Drozdowski W; Stelmasiak Z
    Adv Med Sci; 2014 Mar; 59(1):34-8. PubMed ID: 24797971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.
    Sauter C; Zebenholzer K; Hisakawa J; Zeitlhofer J; Vass K
    Mult Scler; 2008 May; 14(4):500-5. PubMed ID: 18208883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Multiple sclerosis without treatment: characteristic features of 70 untreated patients in a cohort of 1187 patients].
    Sekkat Z; Ongagna JC; Collongues N; Fleury M; Blanc F; de Seze J;
    Rev Neurol (Paris); 2012 Apr; 168(4):338-43. PubMed ID: 22341991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiety and depression in multiple sclerosis patients around diagnosis.
    Giordano A; Granella F; Lugaresi A; Martinelli V; Trojano M; Confalonieri P; Radice D; Solari A;
    J Neurol Sci; 2011 Aug; 307(1-2):86-91. PubMed ID: 21621796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depression in multiple sclerosis.
    Patten SB; Metz LM
    Psychother Psychosom; 1997; 66(6):286-92. PubMed ID: 9403917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
    Fiest KM; Fisk JD; Patten SB; Tremlett H; Wolfson C; Warren S; McKay KA; Berrigan L; Marrie RA;
    Mult Scler Relat Disord; 2015 Sep; 4(5):470-476. PubMed ID: 26346797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depression in multiple sclerosis: a longitudinal analysis.
    Beal CC; Stuifbergen AK; Brown A
    Arch Psychiatr Nurs; 2007 Aug; 21(4):181-91. PubMed ID: 17673110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
    Kisic-Tepavcevic D; Pekmezovic T; Trajkovic G; Stojsavljevic N; Dujmovic I; Mesaros S; Drulovic J
    J Neurol Sci; 2015 Nov; 358(1-2):317-23. PubMed ID: 26384617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depression in multiple sclerosis.
    Patten SB; Marrie RA; Carta MG
    Int Rev Psychiatry; 2017 Oct; 29(5):463-472. PubMed ID: 28681616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression and multiple sclerosis: Review of a lethal combination.
    Wallin MT; Wilken JA; Turner AP; Williams RM; Kane R
    J Rehabil Res Dev; 2006; 43(1):45-62. PubMed ID: 16847771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The dilemma of benign multiple sclerosis: Can we predict the risk of losing the "benign status"? A 12-year follow-up study.
    Razzolini L; Portaccio E; Stromillo ML; Goretti B; Niccolai C; Pastò L; Righini I; Prestipino E; Battaglini M; Giorgio A; De Stefano N; Amato MP
    Mult Scler Relat Disord; 2018 Nov; 26():71-73. PubMed ID: 30237106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysis.
    Hunter A; Marck CH; Butler E; Allan M; Edward KL; Giles A; Kulkarni J; Rajendran D; Shaw S; Grech LB
    Mult Scler Relat Disord; 2021 Nov; 56():103290. PubMed ID: 34614457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comorbidity in multiple sclerosis: Past, present and future.
    Marrie RA
    Clin Invest Med; 2019 Mar; 42(1):E5-E12. PubMed ID: 30904030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.